Adil Mardinoglu is an expert in the field of Systems Biology and Bioinformatics. His recent research activities include the generation of the context specific genome-scale metabolic models for healthy human cell-types e.g. adipocytes, hepatocytes and myocytes as well as certain types of cancer e.g. liver cancer. He employed the reconstructed comprehensive models for revealing the molecular mechanisms of obesity associated diseases as well as for discovery of the novel biomarkers and drug targets.
Dr Mardinoglu is principal investigator in the Systems Biology of the Druggable Proteome program.